In this review, we provide an overview of mechanisms, preclinical studies and advances in clinical trials of DNA-PKcs, ATM/ATR, CHK1/CHK2, WEE1 and PARP1 kinase inhibitors combined with radiotherapy for colorectal cancer treatment. The gene discussed is WEE1; the disease is colorectal cancer.